Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD ResearchDevelopment Group (BIRD)

Autor:	S, Vermeire, E, Louis, O, Dewit, D, Franchimont, T, Moreels, M, Ferrante, J-F, Rahier, Ph, Van Hootegem, M, De Vos, F, Mana, F, Baert
Rok vydání:	2015
Předmět:	Arthritis Rheumatoid Belgium Gastrointestinal Agents Tumor Necrosis Factor-alpha Antirheumatic Agents Adalimumab Antibodies Monoclonal Humans Inflammatory Bowel Diseases Biosimilar Pharmaceuticals Drug Approval Infliximab
Zdroj:	Acta gastro-enterologica Belgica. 78(1)
ISSN:	1784-3227
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::07df7e4fe3f18ba1652086228f4c07db https://pubmed.ncbi.nlm.nih.gov/26118575 Zobrazit plný text záznamu